Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This trial is to investigate efficacy and safety of YKP10811 in Subjects With Irritable Bowel
Syndrome With Constipation. The difference of responder rate between test group (10, 20 and
40mg) and placebo will be evaluated.